Radiopharm Theranostics RADX
NASDAQ RADX
$1.44 -0.18 (-11.11%)
As of: Oct 1, 2026 · 10:36 AM EDT

Radiopharm Theranostics (RADX) Retained Earnings (2024 - 2026)

Updated

Radiopharm Theranostics (RADX) recorded Retained Earnings of -$1.42 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$933,322 a year earlier.

Analysis

Radiopharm Theranostics (RADX) Retained Earnings (2024 - 2026) Analysis & Trends

At the end of FY2026 (ended Jun 30, 2026), Radiopharm Theranostics reported Retained Earnings of -$1.36 million.

  • Across earlier fiscal years, Retained Earnings came in at -$145.73 million in FY2025 and -$111.34 million in FY2024.
  • The fiscal Q4 2026 figure is the lowest quarterly Retained Earnings since fiscal Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 171.67 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -17.33 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 63.27 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 40.86 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 12.59 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -22.28 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 112.09 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 15.69 Bn
10 Radiopharm Theranostics 5.74 Bn 5.70 Bn 186,835.86 -1.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.42 Mn
Jun 30, 2025 -933,322.21
Dec 31, 2024 -127.79 Mn
Jun 30, 2024 -733,749.76
API Access

Radiopharm Theranostics Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=RADX&period=max&api_key=YOUR_API_KEY